|
| Phase → Next Phase |
Core Transition Criteria |
Key Performance Indicators (KPIs) |
Equity Check (Disparities-Sensitive) |
Illustrative Data Sources |
|
|
| 1 Conception → 2 Design |
≥48 states with current prevalence baselines; ≥80% of priority stakeholders engaged |
# stakeholder sessions; % mission statements with measurable targets |
Equity objectives explicitly included (e.g., menthol, targeted marketing) |
CDC NHIS; BRFSS; YRBSS/NYTS; STATE System; state tobacco plans |
|
| 2 Design → 3 Implementation |
≥75% of drafted bills include impact analysis; ≥60% of jurisdictions aligned with federal/state frameworks |
Policy drafting cycle time; # of model ordinances adopted |
Equity impact assessments completed; anti-preemption safeguards documented |
Federal Register; NCSL; state legislature portals |
|
| 3 Implementation → 4 Evaluation |
≥85% of planned campaigns launched; ≥70% retailer inspection coverage; Quitline capacity ≥95% |
Campaign reach (% of population); inspections per 1,000 retailers; NRT adequacy index |
Service reach parity within 10% across racial/SES groups |
FDA compliance database; NAQC reports; state dashboards |
|
| 4 Evaluation → 5 Consolidation |
<8% adult prevalence and ≥20% year-over-year decline in youth vaping |
Data release lag <6 months; policy update latency <120 days |
Reduction in menthol use disparities ≥25% |
MMWR/NYTS; OIG/FDA enforcement logs |
|
| 5 Consolidation → 6 Sustainment |
Endgame package enacted in ≥50% of states; cross-border enforcement coverage ≥80% |
% retailers under supply controls; % targeted cessation coverage |
No widening of disparities during final push |
STATE System; CBP/DOJ taskforce reports |
|
| 6 Sustainment (steady-state) |
Illicit trade cases resolved ≥70%; relapse rate stable/declining over 3 years |
Monitoring frequency; community education renewal rate |
Prevention grants distributed proportional to burden |
CBP/DOJ; state prevention grants |
|
